Sarah K. Happe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sarah K. Happe has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jodi S. Dashe
Department of Obstetrics and Gynecology University of Texas Southwestern Medical Center Dallas Texas USA
4 shared publications Diane M. Twickler
Department of Obstetrics and Gynecology, Division of Maternal‐Fetal Medicine University of Texas Southwestern Medical Center, Parkland Health and Hospital System Dallas TX USA
3 shared publicationsC. Edward Wells
Department of Obstetrics and Gynecology University of Texas Southwestern Medical Center Dallas Texas USA
2 shared publications- Casey S. Yule
Department of Obstetrics and Gynecology, Division of Maternal‐Fetal Medicine University of Texas Southwestern Medical Center, Parkland Health and Hospital System Dallas TX USA
2 shared publications Catherine Y. Spong
Department of Obstetrics and Gynecology, Division of Maternal‐Fetal Medicine University of Texas Southwestern Medical Center, Parkland Health and Hospital System Dallas TX USA
2 shared publications- Diane M. Twickler
University of Texas Southwestern Medical Center, Dallas, TX
2 shared publications
Latest Publications
- 16 March 2021
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 40 (12) , 2735-2743
Transvaginal Color Mapping Ultrasound in the First Trimester Predicts Placenta Accreta Spectrum: A Retrospective Cohort Study
Objectives: Ultrasound (US) prediction of placenta accreta spectrum (PAS) in the first trimester may be aided by postprocessing mechanisms employing color pixel quantification near the bladder–uterine serosal interface. Our objective was to create a postprocessing algorithm of color images to identify findings associated with PAS and compare quantification to sonologist impression in prospectively obtained cine US images.Methods: Transverse transvaginal (TV) US color cines obtained in the first trimester as part of a prospective study were reviewed. Investigators blinded to clinical outcomes reviewed anonymized cines that were archived and labeled the bladder–uterine serosal interface. Color pixels within 2 cm of the defined bladder–uterine serosal interface were ascertained using a Python‐based plugin in the Horos open‐source DICOM viewer. A sonologist classified the findings as suspicious for invasion, indeterminate, or normal. Statistical analysis was performed using Wilcoxon rank‐sum test, Cochran‐Armitage trend test, and calculation of receiver‐operating characteristic (ROC) curves.Results: Fifty‐four studies met inclusion criteria. Of those, six (11%) required hysterectomy with pathologic confirmation of PAS. Women requiring hysterectomy had a significantly higher color Doppler pixel area than those not requiring hysterectomy (P = .0205). A significant trend was identified in the sonologist impression of invasion (P = .0003). ROC's comparing sonologist impression to Doppler color imaging areas were comparable (P = .054).Conclusions: Color Doppler mapping in the first trimester showed an increase in color pixel area near the bladder–uterine serosal interface in women requiring cesarean hysterectomy with histologically confirmed PAS at time of delivery, compared to women without hysterectomy or pathologic evidence of PAS.
- 16 March 2021
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 40 (12) , 2735-2743
Transvaginal Color Mapping Ultrasound in the First Trimester Predicts Placenta Accreta Spectrum: A Retrospective Cohort Study
Objectives: Ultrasound (US) prediction of placenta accreta spectrum (PAS) in the first trimester may be aided by postprocessing mechanisms employing color pixel quantification near the bladder–uterine serosal interface. Our objective was to create a postprocessing algorithm of color images to identify findings associated with PAS and compare quantification to sonologist impression in prospectively obtained cine US images.Methods: Transverse transvaginal (TV) US color cines obtained in the first trimester as part of a prospective study were reviewed. Investigators blinded to clinical outcomes reviewed anonymized cines that were archived and labeled the bladder–uterine serosal interface. Color pixels within 2 cm of the defined bladder–uterine serosal interface were ascertained using a Python‐based plugin in the Horos open‐source DICOM viewer. A sonologist classified the findings as suspicious for invasion, indeterminate, or normal. Statistical analysis was performed using Wilcoxon rank‐sum test, Cochran‐Armitage trend test, and calculation of receiver‐operating characteristic (ROC) curves.Results: Fifty‐four studies met inclusion criteria. Of those, six (11%) required hysterectomy with pathologic confirmation of PAS. Women requiring hysterectomy had a significantly higher color Doppler pixel area than those not requiring hysterectomy (P = .0205). A significant trend was identified in the sonologist impression of invasion (P = .0003). ROC's comparing sonologist impression to Doppler color imaging areas were comparable (P = .054).Conclusions: Color Doppler mapping in the first trimester showed an increase in color pixel area near the bladder–uterine serosal interface in women requiring cesarean hysterectomy with histologically confirmed PAS at time of delivery, compared to women without hysterectomy or pathologic evidence of PAS.
- 14 October 2020
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 40 (8) , 1523-1532
Predicting Placenta Accreta Spectrum
Objectives: The placenta accreta spectrum (PAS) incidence has risen substantially over the past century, paralleling a rise in cesarean delivery (CD) rates. Prenatal diagnosis of PAS improves maternal outcomes. The Placenta Accreta Index (PAI) is a standardized approach to prenatal diagnosis of PAS incorporating clinical risk and ultrasound (US) findings suggestive of placental invasion. We sought to validate the PAI for prediction of PAS in pregnancies with prior CD.Methods: This work was a retrospective cohort study of pregnancies with 1 or more prior CDs that received a US diagnosis of placenta previa or low‐lying placenta in the third trimester. Images of third‐trimester US with a complete placental evaluation were read by 2 blinded physicians, and the PAI was applied. Surgical outcomes and pathologic findings were reviewed. Placenta accreta spectrum was diagnosed if clinical evidence of invasion was seen at time of delivery or if any placental invasion was identified histologically. International Federation of Gynecology and Obstetrics criteria were used.Results: A total of 194 women met inclusion criteria. Cesarean hysterectomy was performed in 92 (47%), CD in 97 (50%), and vaginal delivery in 5 (3%). Of those who underwent hysterectomy, PAS was histologically confirmed in 79 (85%) pregnancies. Of the remaining 13 who underwent hysterectomy, all met International Federation of Gynecology and Obstetrics grade 1 clinical criteria for PAS. With a threshold of greater than 4, the PAI has a sensitivity of 87%, specificity of 77%, positive predictive value of 72%, and negative predictive value of 90% for PAS diagnosis.Conclusions: Contemporaneous application of the PAI, a standardized approach to US diagnosis, is useful in the prenatal prediction of PAS.
- 14 October 2020
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 40 (8) , 1523-1532
Predicting Placenta Accreta Spectrum
Objectives: The placenta accreta spectrum (PAS) incidence has risen substantially over the past century, paralleling a rise in cesarean delivery (CD) rates. Prenatal diagnosis of PAS improves maternal outcomes. The Placenta Accreta Index (PAI) is a standardized approach to prenatal diagnosis of PAS incorporating clinical risk and ultrasound (US) findings suggestive of placental invasion. We sought to validate the PAI for prediction of PAS in pregnancies with prior CD.Methods: This work was a retrospective cohort study of pregnancies with 1 or more prior CDs that received a US diagnosis of placenta previa or low‐lying placenta in the third trimester. Images of third‐trimester US with a complete placental evaluation were read by 2 blinded physicians, and the PAI was applied. Surgical outcomes and pathologic findings were reviewed. Placenta accreta spectrum was diagnosed if clinical evidence of invasion was seen at time of delivery or if any placental invasion was identified histologically. International Federation of Gynecology and Obstetrics criteria were used.Results: A total of 194 women met inclusion criteria. Cesarean hysterectomy was performed in 92 (47%), CD in 97 (50%), and vaginal delivery in 5 (3%). Of those who underwent hysterectomy, PAS was histologically confirmed in 79 (85%) pregnancies. Of the remaining 13 who underwent hysterectomy, all met International Federation of Gynecology and Obstetrics grade 1 clinical criteria for PAS. With a threshold of greater than 4, the PAI has a sensitivity of 87%, specificity of 77%, positive predictive value of 72%, and negative predictive value of 90% for PAS diagnosis.Conclusions: Contemporaneous application of the PAI, a standardized approach to US diagnosis, is useful in the prenatal prediction of PAS.
- 1 June 2020
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 214 (6) , 1417-1423
Placenta Accreta Spectrum: Correlation of MRI Parameters With Pathologic and Surgical Outcomes of High-Risk Pregnancies
OBJECTIVE. The purpose of this study is to determine whether MRI parameters of placenta accreta spectrum (PAS) correlate with pathologic and surgical outcomes in high-risk pregnancies. MATERIALS AN...
- 1 June 2020
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 214 (6) , 1417-1423
Placenta Accreta Spectrum: Correlation of MRI Parameters With Pathologic and Surgical Outcomes of High-Risk Pregnancies
OBJECTIVE. The purpose of this study is to determine whether MRI parameters of placenta accreta spectrum (PAS) correlate with pathologic and surgical outcomes in high-risk pregnancies. MATERIALS AN...
- 6 May 2020
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 39 (10) , 1907-1915
Prospective First‐Trimester Ultrasound Imaging of Low Implantation and Placenta Accreta Spectrum
Objectives: To prospectively evaluate low implantation of the gestational sac and other first‐trimester ultrasound (US) parameters for prediction of placenta accreta spectrum (PAS).Methods: Women with a diagnosis of low implantation on clinically indicated first‐trimester US underwent a transvaginal US examination at 10 to 13 weeks’ gestation to assess the trophoblast location, anechoic areas, bridging vessels, and smallest myometrial thickness (SMT). The placental location was evaluated in the second trimester, and serial US examinations were performed in cases of low placentation. Placenta accreta spectrum was based on clinical findings and confirmed by histologic results.Results: Of 68 women, 40 (59%) had prior cesarean delivery (CD). Hysterectomy was performed in 8, all with prior CD. Of these, 7 (88%) had US suspicion of PAS. In 16 with prior CD and basalis overlying the internal os, 9 (56%) had second‐trimester placenta previa, and 7 of 9 (78%) underwent hysterectomy with pathologic confirmation of PAS. Of 28 without prior CD, there were no cases of persistent low placentation in the third trimester regardless of the trophoblast location. Ultrasound parameters associated with PAS were a smaller distance from the inferior trophoblastic border to the external os, disruption of the bladder‐serosal interface, bridging vessels, anechoic areas, and the SMT. In women with prior CD, use of the SMT in the sagittal plane yielded an area under the receiver operating characteristic curve of 0.96 (95% confidence interval, 0.91–1.00).Conclusions: First‐trimester low implantation increases the risk of persistent placenta previa and PAS in women with prior CD. All parameters were associated with PAS, the most predictive being the SMT.
- 6 May 2020
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 39 (10) , 1907-1915
Prospective First‐Trimester Ultrasound Imaging of Low Implantation and Placenta Accreta Spectrum
Objectives: To prospectively evaluate low implantation of the gestational sac and other first‐trimester ultrasound (US) parameters for prediction of placenta accreta spectrum (PAS).Methods: Women with a diagnosis of low implantation on clinically indicated first‐trimester US underwent a transvaginal US examination at 10 to 13 weeks’ gestation to assess the trophoblast location, anechoic areas, bridging vessels, and smallest myometrial thickness (SMT). The placental location was evaluated in the second trimester, and serial US examinations were performed in cases of low placentation. Placenta accreta spectrum was based on clinical findings and confirmed by histologic results.Results: Of 68 women, 40 (59%) had prior cesarean delivery (CD). Hysterectomy was performed in 8, all with prior CD. Of these, 7 (88%) had US suspicion of PAS. In 16 with prior CD and basalis overlying the internal os, 9 (56%) had second‐trimester placenta previa, and 7 of 9 (78%) underwent hysterectomy with pathologic confirmation of PAS. Of 28 without prior CD, there were no cases of persistent low placentation in the third trimester regardless of the trophoblast location. Ultrasound parameters associated with PAS were a smaller distance from the inferior trophoblastic border to the external os, disruption of the bladder‐serosal interface, bridging vessels, anechoic areas, and the SMT. In women with prior CD, use of the SMT in the sagittal plane yielded an area under the receiver operating characteristic curve of 0.96 (95% confidence interval, 0.91–1.00).Conclusions: First‐trimester low implantation increases the risk of persistent placenta previa and PAS in women with prior CD. All parameters were associated with PAS, the most predictive being the SMT.
- Open Access
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S222
367: Validation of the placenta accreta index to predict morbidly adherent placenta
- 1 January 2017
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 216 (1) , S222
Open Access367: Validation of the placenta accreta index to predict morbidly adherent placenta
- 1 December 2016
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 128 (6) , 1437-1440
Microangiopathic Hemolytic Anemia Due to Malignancy in Pregnancy
Microangiopathic disorders during pregnancy remain a diagnostic challenge because these conditions often imitate more common obstetric diseases. A 31-year-old multigravid woman delivered at term with a postpartum course complicated by laboratory indices consistent with hemolysis, elevated liver enzymes, and low platelet count syndrome. After clinical recovery, she was readmitted 2 weeks after delivery with presumptive pyelonephritis. Persistent hemolysis and worsening thrombocytopenia suggested a diagnosis of thrombotic microangiopathy, which did not respond to plasma exchange. Directed bone biopsy revealed metastatic signet ring cell adenocarcinoma. Microangiopathic hemolytic anemia is rarely the initial clinical manifestation of malignancy. Given the similar features of several common obstetric complications, additional diagnostic measures may be necessary to refine the diagnosis in cases unresponsive to standard obstetric management.
- 1 December 2016
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 128 (6) , 1437-1440
Microangiopathic Hemolytic Anemia Due to Malignancy in Pregnancy
Microangiopathic disorders during pregnancy remain a diagnostic challenge because these conditions often imitate more common obstetric diseases. A 31-year-old multigravid woman delivered at term with a postpartum course complicated by laboratory indices consistent with hemolysis, elevated liver enzymes, and low platelet count syndrome. After clinical recovery, she was readmitted 2 weeks after delivery with presumptive pyelonephritis. Persistent hemolysis and worsening thrombocytopenia suggested a diagnosis of thrombotic microangiopathy, which did not respond to plasma exchange. Directed bone biopsy revealed metastatic signet ring cell adenocarcinoma. Microangiopathic hemolytic anemia is rarely the initial clinical manifestation of malignancy. Given the similar features of several common obstetric complications, additional diagnostic measures may be necessary to refine the diagnosis in cases unresponsive to standard obstetric management.